Results 201 to 210 of about 38,934 (294)

Neutrophil-to-Lymphocyte Ratio as a Marker of Diabetic Ketoacidosis Severity in Type 1 Diabetes Mellitus: A Retrospective Study. [PDF]

Cureus
Alduraibi RK, Alsaawi OK, Alkhulayfi AA, Aljumaah NY, Alharbi IK, Alharbi EA.   +5 more
europepmc   +1 more source

Clinically significant hypoglycaemia in hospitalised adults: A multicentre study of 1205 episodes in the United Kingdom

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Introduction and Objectives Inpatient hypoglycaemia is a serious complication of diabetes therapy, yet real‐world data on clinically significant episodes remain limited. The objectives of this study are (1) to describe the clinical and biochemical characteristics of clinically significant inpatient hypoglycaemia across multiple NHS sites, (2 ...
Charles Page, Mariam Idrissi, Sam Sherratt‐Mayhew, Aashritha Buchipudi, Amanda Ling Jie Yee, Kalyaani Persad, Aqeelah Khatoon, Amrit Rakkar, Amynta Arshad, Alexandra Lubina Solomon, Rajeev Raghavan, Lakshmi Rengarajan, Ahmed Iqbal, Pratik Choudhary, Aspasia Manta, Punith Kempegowda, DEVI Collaboration   +16 more
wiley   +1 more source

SGLT-2 inhibitor-associated significant hypernatremia and euglycemic diabetic ketoacidosis after cardiac surgery: a case series. [PDF]

J Cardiothorac Surg
Bian EZ, Zou WW, Zhu QK, Zhuang WZ, Chen JM, Cen JZ, Gao Q.   +6 more
europepmc   +1 more source

Antibiotic Exposure in Early Life and Risk of Type 1 Diabetes: A Meta‐Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4653-4670, June 2026.
ABSTRACT Background Early‐life antibiotic use may increase the risk of childhood type 1 diabetes (T1D), potentially through gut microbiota dysbiosis and associated effects on immune development. This meta‐analysis evaluated associations between early‐life antibiotic use and T1D.
Sharan Ram, Marine Corbin, Andrea ’t Mannetje, Jeroen Douwes, Amanda Kvalsvig, Amanda Eng   +5 more
wiley   +1 more source

Risk of recurrent diabetic ketoacidosis following initiation of sodium-glucose co-transporter 2 inhibitors in patients with an insulin-deficient diabetes and prior diabetic ketoacidosis: An observational cohort study. [PDF]

Diabetes Obes Metab
Tsur A, Hamtzany O, Pollack R, Cahn A.
europepmc   +1 more source

Demographic Change in Prevalent Type 1 Diabetes Adult Population, and Association of Risk Factors With Comorbidities and Mortality—Results From the Finnish Diabetes Control Study FinDiCon

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4683-4695, June 2026.
ABSTRACT Aims The objective was to characterise Finnish adults with type 1 diabetes (T1D) and to explore associations between known risk factors, comorbidities and mortality. Materials and Methods Individuals with T1D in 2014–2021 were identified from national health care registers, and data on medication and comorbidities were combined with laboratory
Hannu Vessari, Tuire Prami, Essi J. Peltonen, Elina Pimiä, Ilona Iso‐Mustajärvi, Marita Kalaoja, Hanne Luoto, Ilkka Vauhkonen, Tero Saukkonen   +8 more
wiley   +1 more source

Clinical characteristics and outcomes of diabetic ketoacidosis in patients with type 2 diabetes during acute systemic stress. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Mohamed RASAA, Hendawy LMA, Farghaly EEM, Saleh AMMAEH.   +3 more
europepmc   +1 more source

Cost‐Effectiveness of Automated Insulin Delivery Systems in Paediatrics, T1D and T2D Adults Across Four Nordic Countries

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4784-4794, June 2026.
ABSTRACT Aims This study evaluated long‐term cost‐effectiveness of automated insulin delivery (AID) systems versus multiple daily injections (MDI) + CGM in children with type 1 diabetes (T1D), adults with T1D and insulin‐treated individuals with type 2 diabetes (T2D) across Denmark, Finland, Norway and Sweden.
Johan Jendle, Kirsten Nørgaard, Elina Pimiä, Heiko Bratke, Aesha Khan Mirón, Maria‐Eleni Syleouni   +5 more
wiley   +1 more source

A Case of Euglycemic Diabetic Ketoacidosis With Tirzepatide Use and Severe Calorie Restriction. [PDF]

JCEM Case Rep
Raptis D, Theodoropoulos P, Shah MK, Bloomgarden N, Kishore P.   +4 more
europepmc   +1 more source

Artificial Intelligence in Type 1 Diabetes Management: A Scoping Review of Randomised Controlled Trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4860-4875, June 2026.
ABSTRACT Background Artificial intelligence is emerging in healthcare systems. In type 1 diabetes, AI‐enabled tools are increasingly used to support nutrition assessment and insulin decision‐making, yet their clinical utility and safety remain unclear. Methods The study aims to identify and map the evidence on the clinical utility of AI‐based diabetes ...
Yucen Wu, Jun Pang, Shaoyong Xu, Lalantha Leelarathna, Aaron M. Lett   +4 more
wiley   +1 more source